Company · CIK 1111485
RxSight, Inc.
| CIK | 1111485 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 3851 — Ophthalmic Goods |
| Incorporated in | DE |
| Business address | CA |
| Listed | RXST (Nasdaq) |
| First annual or quarterly report | 2021-09-09 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-279206 | 2024-05-08 | 2026-02-26 | 4 | |
| 333-266651 | 2022-08-08 | 2023-02-08 | 5 | |
| 333-257790 | 2021-07-09 | 2021-07-30 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-02-26 | EFFECTDeclared effective | 333-279206 | 9999999995-26-000671 |
| 2024-05-09 | 424B5Shelf takedown | 333-279206 | 0001193125-24-135359 |
| 2024-05-08 | 424B5Shelf takedown | 333-279206 | 0001193125-24-134286 |
| 2024-05-08 | S-3ASRShelf registered | 333-279206 | 0001193125-24-134187 |
| 2023-02-08 | 424B5Shelf takedown | 333-266651 | 0001193125-23-028387 |
| 2023-02-07 | 424B5Shelf takedown | 333-266651 | 0001193125-23-027125 |
| 2022-08-12 | EFFECTDeclared effective | 333-266651 | 9999999995-22-002372 |
| 2022-08-12 | 424B5Shelf takedown | 333-266651 | 0001193125-22-220048 |
| 2022-08-08 | S-3Shelf registered | 333-266651 | 0001193125-22-214924 |
| 2021-07-30 | 424B4Final prospectus | 333-257790 | 0001193125-21-231508 |
| 2021-07-29 | EFFECTDeclared effective | 333-257790 | 9999999995-21-002978 |
| 2021-07-28 | S-1/AAmendment | 333-257790 | 0001193125-21-226143 |
| 2021-07-26 | S-1/AAmendment | 333-257790 | 0001193125-21-223690 |
| 2021-07-09 | S-1Registration filed | 333-257790 | 0001193125-21-211793 |
| 2021-05-17 | DRSDraft made public | 377-04880 | 0000950123-21-006634 |